{{Rsnum
|rsid=6254
|Gene=PTH
|Chromosome=11
|position=13492716
|Orientation=minus
|GMAF=0.2112
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PTH
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.0 | 51.3 | 40.7
| HCB | 0.7 | 19.1 | 80.1
| JPT | 2.7 | 13.3 | 84.1
| YRI | 0.7 | 7.5 | 91.8
| ASW | 12.3 | 24.6 | 63.2
| CHB | 0.7 | 19.1 | 80.1
| CHD | 1.8 | 18.3 | 79.8
| GIH | 3.0 | 32.7 | 64.4
| LWK | 0.0 | 16.4 | 83.6
| MEX | 1.7 | 37.9 | 60.3
| MKK | 6.4 | 42.9 | 50.6
| TSI | 15.7 | 38.2 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=19557980
|Title=Parathyroid hormone gene variant and calcific aortic stenosis
}}

{{PMID|18285546|OA=1
}} A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.

{{PMID|18551993}} SNP combinations in chromosome-wide genes are associated with bone mineral density in Taiwanese women.

{{PMID Auto
|PMID=24903972
|Title=Genetic predisposition to calcific aortic stenosis and mitral annular calcification
}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}